Detalhe da pesquisa
1.
Transcription elongation defects link oncogenic SF3B1 mutations to targetable alterations in chromatin landscape.
Mol Cell
; 84(8): 1475-1495.e18, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38521065
2.
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures.
Blood
; 141(19): 2359-2371, 2023 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36626250
3.
Breakthrough invasive fungal infections on isavuconazole prophylaxis in hematologic malignancy & hematopoietic stem cell transplant patients.
Transpl Infect Dis
; 25 Suppl 1: e14162, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794708
4.
What are the most promising new agents in myelodysplastic syndromes?
Curr Opin Hematol
; 26(2): 77-87, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30632987
5.
Updates on the use of neoadjuvant therapy in borderline resectable pancreatic cancer.
JOP
; 15(2): 91-4, 2014 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24618425
6.
PD-1H/VISTA mediates immune evasion in acute myeloid leukemia.
J Clin Invest
; 134(3)2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060328
7.
Transcription elongation defects link oncogenic splicing factor mutations to targetable alterations in chromatin landscape.
bioRxiv
; 2023 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36891287
8.
What constitutes meaningful improvement in myelodysplastic syndromes?
Leuk Lymphoma
; 63(11): 2528-2535, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699987
9.
Peripheral Blood Involvement at Staging in Patients With Aggressive Peripheral T-Cell Lymphoma.
Clin Lymphoma Myeloma Leuk
; 22(9): 680-689, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568635
10.
Molecular characteristics and outcomes in Hispanic and non-Hispanic patients with acute myeloid leukemia.
EJHaem
; 3(4): 1231-1240, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36467830
11.
In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2.
Leukemia
; 36(5): 1313-1323, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35273342
12.
Hypomethylating agent based combinations in higher risk myelodysplastic syndrome.
Leuk Lymphoma
; 61(5): 1012-1027, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31814484
13.
Advances in non-intensive chemotherapy treatment options for adults diagnosed with acute myeloid leukemia.
Leuk Res
; 91: 106339, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32146154
14.
Insights into novel emerging epigenetic drugs in myeloid malignancies.
Ther Adv Hematol
; 10: 2040620719866081, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31431820
15.
Combining lenalidomide with erythropoiesis stimulating agents: a party of one.
Leukemia
; 38(3): 473-474, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38360864
16.
E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial.
Leukemia
; 37(12): 2512-2516, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37814121
17.
Just and Equitable Enrollment to Pivotal Clinical Trials in Hematologic Malignancies.
J Clin Oncol
; 40(32): 3677-3680, 2022 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36037412
18.
A little CIN may cost a lot: revisiting aneuploidy and cancer.
Curr Opin Genet Dev
; 19(1): 74-81, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19195877
19.
Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes.
Genes Dev
; 22(16): 2189-203, 2008 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18662975